BioCryst Pharmaceuticals | BCRX - Action





Action Changement Date
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Chugai Pharma JPY 276.85B 30.52B 2025-12
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 115.62M 14.56M 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novavax USD 11.46M 87K 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 1B 86.37M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03